SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-031093
Filing Date
2024-03-05
Accepted
2024-03-05 17:15:30
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm247653d1_sc13da.htm SC 13D/A 75567
2 EXHIBIT 99.6 tm247653d1_ex99-6.htm EX-99.6 30396
  Complete submission text file 0001104659-24-031093.txt   107917
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683
Business Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 (360) 949-1041
Absci Corp (Subject) CIK: 0001672688 (see all company filings)

IRS No.: 853383487 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92724 | Film No.: 24722263
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)